These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23315266)

  • 21. Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
    Bakuła Z; Napiórkowska A; Kamiński M; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J; Jagielski T
    J Microbiol Immunol Infect; 2016 Jun; 49(3):439-44. PubMed ID: 26117528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of critical concentrations of second-line anti-tuberculosis drugs with clinical and microbiological relevance.
    Kam KM; Sloutsky A; Yip CW; Bulled N; Seung KJ; Zignol M; Espinal M; Kim SJ
    Int J Tuberc Lung Dis; 2010 Mar; 14(3):282-8. PubMed ID: 20132618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pattern of ethionamide susceptibility and its association with isoniazid resistance among previously treated tuberculosis patients from India.
    Lakshmi R; Kumar V; Baskaran M; Sundar S; Rahman F; Selvakumar N; Ramachandran R
    Braz J Infect Dis; 2011; 15(6):619-20. PubMed ID: 22218528
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug Resistance Characteristics of
    Wu X; Yang J; Tan G; Liu H; Liu Y; Guo Y; Gao R; Wan B; Yu F
    Front Cell Infect Microbiol; 2019; 9():345. PubMed ID: 31828045
    [No Abstract]   [Full Text] [Related]  

  • 25. Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis.
    Vilchèze C; Av-Gay Y; Attarian R; Liu Z; Hazbón MH; Colangeli R; Chen B; Liu W; Alland D; Sacchettini JC; Jacobs WR
    Mol Microbiol; 2008 Sep; 69(5):1316-29. PubMed ID: 18651841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
    Kam KM; Yip CW
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance of multidrug-resistant strains of Mycobacterium tuberculosis from the Archangel oblast, Russia, to second-line anti-tuberculosis drugs.
    Toungoussova OS; Mariandyshev AO; Bjune G; Caugant DA; Sandven P
    Eur J Clin Microbiol Infect Dis; 2005 Mar; 24(3):202-6. PubMed ID: 15742171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotypic analysis of genes associated with isoniazid and ethionamide resistance in MDR-TB isolates from Thailand.
    Boonaiam S; Chaiprasert A; Prammananan T; Leechawengwongs M
    Clin Microbiol Infect; 2010 Apr; 16(4):396-9. PubMed ID: 19486070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugs.
    Kurbatova EV; Cavanaugh JS; Shah NS; Wright A; Kim H; Metchock B; Van Deun A; Barrera L; Boulahbal F; Richter E; Martín-Casabona N; Arias F; Zemanova I; Drobniewski F; Santos Silva A; Coulter C; Lumb R; Cegielski JP
    Int J Tuberc Lung Dis; 2012; 16(3):355-7. PubMed ID: 22640449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular investigation of resistance to the antituberculous drug ethionamide in multidrug-resistant clinical isolates of Mycobacterium tuberculosis.
    Brossier F; Veziris N; Truffot-Pernot C; Jarlier V; Sougakoff W
    Antimicrob Agents Chemother; 2011 Jan; 55(1):355-60. PubMed ID: 20974869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New generation methods for drug susceptibility testing for tuberculosis.
    Katoch VM
    Indian J Tuberc; 2008 Apr; 55(2):61-3. PubMed ID: 18516820
    [No Abstract]   [Full Text] [Related]  

  • 32. [Surveillance of antituberculosis-drug resistance in Cuba, 2010-2011].
    Lemus D; Echemendía M; Díaz R; Llop A; Llanes MJ
    Biomedica; 2014 Apr; 34 Suppl 1():108-13. PubMed ID: 24968042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changing prevalence and resistance patterns in children with drug-resistant tuberculosis in Mumbai.
    Shah I; Shah F
    Paediatr Int Child Health; 2017 May; 37(2):135-138. PubMed ID: 27686119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the susceptibility testing of clinical isolates of Mycobacterium tuberculosis by the XTT colorimetric method and the NCCLS standards method.
    De Logu A; Pellerano ML; Sanna A; Pusceddu MC; Uda P; Saddi B
    Int J Antimicrob Agents; 2003 Mar; 21(3):244-50. PubMed ID: 12636986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility tests to second line drugs and re-treatment of tuberculosis revisiting early experiences.
    de Kantor IN; Barrera L
    Medicina (B Aires); 2007; 67(3):231-7. PubMed ID: 17628909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Multilaboratory, Multicountry Study To Determine MIC Quality Control Ranges for Phenotypic Drug Susceptibility Testing of Selected First-Line Antituberculosis Drugs, Second-Line Injectables, Fluoroquinolones, Clofazimine, and Linezolid.
    Kaniga K; Cirillo DM; Hoffner S; Ismail NA; Kaur D; Lounis N; Metchock B; Pfyffer GE; Venter A
    J Clin Microbiol; 2016 Dec; 54(12):2963-2968. PubMed ID: 27654338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss-of-function mutations in
    Pandey S; Vilchèze C; Werngren J; Bainomugisa A; Mansjö M; Groenheit R; Miotto P; Cirillo DM; Coulter C; Baulard AR; Schön T; Jacobs WR; Djaout K; Köser CU
    Antimicrob Agents Chemother; 2024 Jan; 68(1):e0109623. PubMed ID: 38038476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.
    Niehaus AJ; Mlisana K; Gandhi NR; Mathema B; Brust JC
    PLoS One; 2015; 10(9):e0135003. PubMed ID: 26332235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenylethyl butyrate enhances the potency of second-line drugs against clinical isolates of Mycobacterium tuberculosis.
    Grau T; Selchow P; Tigges M; Burri R; Gitzinger M; Böttger EC; Fussenegger M; Sander P
    Antimicrob Agents Chemother; 2012 Feb; 56(2):1142-5. PubMed ID: 22106218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of MODS assay for rapid detection of Mycobacterium tuberculosis resistance to second-line drugs in a tertiary care tuberculosis hospital in China.
    Huang Z; Li G; Chen J; Li W; Xu X; Luo Q; Xiong G; Sun J; Li J
    Tuberculosis (Edinb); 2014 Sep; 94(5):506-10. PubMed ID: 25082461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.